Danske Bank A/S Abbott Laboratories Transaction History
Danske Bank A/S
- $1.95 Trillion
- Q3 2025
A detailed history of Danske Bank A/S transactions in Abbott Laboratories stock. As of the latest transaction made, Danske Bank A/S holds 7,143 shares of ABT stock, worth $932,804. This represents 0.05% of its overall portfolio holdings.
Number of Shares
7,143Holding current value
$932,804% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,647Shares Held
1.38BCall Options Held
10.2MPut Options Held
9.04M-
Vanguard Group Inc Valley Forge, PA173MShares$22.6 Billion0.36% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.2MShares$10.2 Billion0.37% of portfolio
-
Capital International Investors Los Angeles, CA61.6MShares$8.05 Billion1.4% of portfolio
-
Capital Research Global Investors Los Angeles, CA38.8MShares$5.06 Billion1.02% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $229B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...